Corrigendum to "Overexpression of integrin-linked kinase (ILK) promotes migration and invasion of colorectal cancer cells by inducing epithelial-mesenchymal transition via NF-κB signaling" [Acta Histochem. 116 (3) (2014) 527-533] Doi: 10.1016/j.acthis.2013.11.001;Overexpression of integrin-linked kinase (ILK) promotes migration and invasion of colorectal cancer cells by inducing epithelial-mesenchymal transition via NF-κB signaling

Acta Histochemica

Volumn 116, Issue 3, 2014, Pages 527-533

  Yan, Zhaopeng ^a   Yin, Hongzhuan ^a   Wang, Rui ^a   Wu, Di ^a   Sun, Wei ^a   Liu, Baolin ^a   Su, Qi ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

Colorectal cancer; Epithelial mesenchymal transition; Integrin linked kinase; Invasion; Migration; Nuclear factor B

Indexed keywords

3 (4 METHYLPHENYLSULFONYL) 2 PROPENENITRILE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTEGRIN LINKED KINASE; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR RELA; TRANSCRIPTION FACTOR SLUG; TRANSCRIPTION FACTOR SNAIL; UVOMORULIN; VIMENTIN; CADHERIN; CDH1 PROTEIN, HUMAN; INTEGRIN-LINKED KINASE; PROTEIN SERINE THREONINE KINASE;

ARTICLE; CANCER CELL; CELL INVASION; CELL MIGRATION; COLORECTAL CANCER; CONTROLLED STUDY; EPITHELIAL MESENCHYMAL TRANSITION; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; IN VITRO STUDY; SIGNAL TRANSDUCTION; WESTERN BLOTTING; CELL MOTION; COLORECTAL TUMOR; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; TUMOR CELL LINE; TUMOR INVASION;

GASTROPODA;

CADHERINS; CELL LINE, TUMOR; CELL MOVEMENT; COLORECTAL NEOPLASMS; EPITHELIAL-MESENCHYMAL TRANSITION; GENE EXPRESSION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; NEOPLASM INVASIVENESS; NF-KAPPA B; PROTEIN-SERINE-THREONINE KINASES; SIGNAL TRANSDUCTION;

EID: 84899973915     PISSN: 00651281     EISSN: 16180372     Source Type: Journal    
DOI: 10.1016/j.acthis.2015.01.002     Document Type: Erratum

References (33)

1. Andre N., Schmiegel W. Chemoradiotherapy for colorectal cancer. Gut 2005, 54:1194-1202.
2. Barker N., Clevers H. Tumor environment: a potent driving force in colorectal cancer?. Trends Mol Med 2001, 7:535-537.
3. Becker-Santos D.D., Guo Y., Ghaffari M., Vickers E.D., Lehman M., Altamirano-Dimas M., et al. Integrin-linked kinase as a target for ERG-mediated invasive properties in prostate cancer models. Carcinogenesis 2012, 33:2558-2567.
4. Brabletz T., Hlubek F., Spaderna S., Schmalhofer O., Hiendlmeyer E., Jung A., et al. Invasion and metastasis in colorectal cancer: epithelial-mesenchymal transition, mesenchymal-epithelial transition, stem cells and beta-catenin. Cells Tissues Organs 2005, 179:56-65.
5. Bravou V., Klironomos G., Papadaki E., Taraviras S., Varakis J. ILK over-expression in human colon cancer progression correlates with activation of beta-catenin, down-regulation of E-cadherin and activation of the Akt-FKHR pathway. J Pathol 2006, 208:91-99.
6. Bujanda L., Sarasqueta C., Hijona E., Hijona L., Cosme A., Gil I., et al. Colorectal cancer prognosis twenty years later. World J Gastroenterol 2010, 16:862-867.
7. Chen D., Zhang Y., Zhang X., Li J., Han B., Liu S., et al. Overexpression of integrin-linked kinase correlates with malignant phenotype in non-small cell lung cancer and promotes lung cancer cell invasion and migration via regulating epithelial-mesenchymal transition (EMT)-related genes. Acta Histochem 2013, 115:128-136.
8. Davies R.J., Miller R., Coleman N. Colorectal cancer screening: prospects for molecular stool analysis. Nat Rev Cancer 2005, 5:199-209.
9. Durbin A.D., Hannigan G.E., Malkin D. Oncogenic ILK, tumor suppression and all that JNK. Cell Cycle 2009, 8:4060-4066.
10. Gil D., Ciolczyk-Wierzbicka D., Dulinska-Litewka J., Zwawa K., McCubrey J.A., Laidler P. The mechanism of contribution of integrin linked kinase (ILK) to epithelial-mesenchymal transition (EMT). Adv Enzyme Regul 2011, 51:195-207.
11. Hannigan G., Troussard A.A., Dedhar S. Integrin-linked kinase: a cancer therapeutic target unique among its ILK. Nat Rev Cancer 2005, 5:51-63.
12. Hannigan G.E., Leung-Hagesteijn C., Fitz-Gibbon L., Coppolino M.G., Radeva G., Filmus J., et al. Regulation of cell adhesion and anchorage-dependent growth by a new beta 1-integrin-linked protein kinase. Nature 1996, 379:91-96.
13. Jemal A., Bray F., Center M.M., Ferlay J., Ward E., Forman D. Global cancer statistics. CA Cancer J Clin 2011, 61:69-90.
14. Kalluri R., Weinberg R.A. The basics of epithelial-mesenchymal transition. J Clin Invest 2009, 119:1420-1428.
15. Lee J.M., Dedhar S., Kalluri R., Thompson E.W. The epithelial-mesenchymal transition: new insights in signaling, development, and disease. J Cell Biol 2006, 172:973-981.
16. Li J., Yang Z.L., Ren X., Zou Q., Yuan Y., Liang L., et al. ILK and PRDX1 are prognostic markers in squamous cell/adenosquamous carcinomas and adenocarcinoma of gallbladder. Tumour Biol 2013, 34:359-368.
17. Li J., Zhang H., Wu J., Guan H., Yuan J., Huang Z., et al. Prognostic significance of integrin-linked kinase1 overexpression in astrocytoma. Int J Cancer 2010, 126:1436-1444.
18. Li R., Liu B., Yin H., Sun W., Yin J., Su Q. Overexpression of integrin-linked kinase (ILK) is associated with tumor progression and an unfavorable prognosis in patients with colorectal cancer. J Mol Histol 2013, 44:183-189.
19. Liang F., Zhang S., Wang B., Qiu J., Wang Y. Overexpression of integrin-linked kinase (ILK) promotes glioma cell invasion and migration and down-regulates E-cadherin via the NF-kappaB pathway. J Mol Histol 2013, 10.1007/s10735-013-9540-5.
20. Lurje G., Zhang W., Lenz H.J. Molecular prognostic markers in locally advanced colon cancer. Clin Colorectal Cancer 2007, 6:683-690.
21. Matsui Y., Assi K., Ogawa O., Raven P.A., Dedhar S., Gleave M.E., et al. The importance of integrin-linked kinase in the regulation of bladder cancer invasion. Int J Cancer 2012, 130:521-531.
22. McDonald P.C., Fielding A.B., Dedhar S. Integrin-linked kinase - essential roles in physiology and cancer biology. J Cell Sci 2008, 121:3121-3132.
23. Min C., Eddy S.F., Sherr D.H., Sonenshein G.E. NF-kappaB and epithelial to mesenchymal transition of cancer. J Cell Biochem 2008, 104:733-744.
24. Nieto M.A. The ins and outs of the epithelial to mesenchymal transition in health and disease. Annu Rev Cell Dev Biol 2011, 27:347-376.
25. Ricci-Vitiani L., Mollinari C., di Martino S., Biffoni M., Pilozzi E., Pagliuca A., et al. Thymosin beta4 targeting impairs tumorigenic activity of colon cancer stem cells. FASEB J 2010, 24:4291-4301.
26. Schaeffer D.F., Assi K., Chan K., Buczkowski A.K., Chung S.W., Scudamore C.H., et al. Tumor expression of integrin-linked kinase (ILK) correlates with the expression of the E-cadherin repressor snail: an immunohistochemical study in ductal pancreatic adenocarcinoma. Virchows Arch 2010, 456:261-268.
27. Serrano I., McDonald P.C., Lock F.E., Dedhar S. Role of the integrin-linked kinase (ILK)/Rictor complex in TGFbeta-1-induced epithelial-mesenchymal transition (EMT). Oncogene 2013, 32:50-60.
28. Thiery J.P., Acloque H., Huang R.Y., Nieto M.A. Epithelial-mesenchymal transitions in development and disease. Cell 2009, 139:871-890.
29. Wani A.A., Jafarnejad S.M., Zhou J., Li G. Integrin-linked kinase regulates melanoma angiogenesis by activating NF-kappaB/interleukin-6 signaling pathway. Oncogene 2011, 30:2778-2788.
30. Watzka S.B., Rauscher-Potsch I., Stubenberger E., Getman V., Setinek U., Totsch M., et al. Immunoreactivity of integrin-linked kinase in primary non-small-cell lung cancer and survival after curative resection. Eur J Cardiothorac Surg 2010, 38:254-259.
31. Xing Y., Qi J., Deng S., Wang C., Zhang L., Chen J. Small interfering RNA targeting ILK inhibits metastasis in human tongue cancer cells through repression of epithelial-to-mesenchymal transition. Exp Cell Res 2013, 319:2058-2072.
32. Yu J., Shi R., Zhang D., Wang E., Qiu X. Expression of integrin-linked kinase in lung squamous cell carcinoma and adenocarcinoma: correlation with E-cadherin expression, tumor microvessel density and clinical outcome. Virchows Arch 2011, 458:99-107.
33. Zhao D., Tang X.F., Yang K., Liu J.Y., Ma X.R. Over-expression of integrin-linked kinase correlates with aberrant expression of Snail, E-cadherin and N-cadherin in oral squamous cell carcinoma: implications in tumor progression and metastasis. Clin Exp Metastasis 2012, 29:957-969.